Shanghai SIPI Pharmaceutical Co., Ltd
Shanghai SIPI Pharmaceutical Co., Ltd is a Manufacturer. Main products and services: Zidovudine, Azithromycin, Alpha lipoic acid, Clarithromycin, Sibutramine hcl, Etoposide, Fenfluramine, Pravastatin sodiu….
Company Profile
Shanghai SIPI Pharmaceutical Co., ltd, a state-owned group of companies headquartered in Shanghai, possesses four manufacturing divisions supplying APIs, herbal extract products, bio-chemicals and formulations.
Started in the year 1979, SIPI Pharma was set up and invested by Shanghai Institute of Pharmaceutical Industry (SIPI), a most comprehensive and China's supreme pharmaceutical research institute founded in 1957, with 700 strong force of chemical engineers.
Initially the company acted as a pilot plant venture of SIPI, offering manufacturing capabilities from gram scale-up to multi-ton lots for compounds under development. Over the nearly 30 years expanding, SIPI Pharma has a formidable presence in pharma field with registered capital over USD10 million, consists of four spacious manufacturing facilities in Shanghai with GMP certified, and more than on thousand employees.
The strong R&D strengths of SIPI made her company stand out from all other suppliers: An innovation-based company with disciplined practices of synthesis, providing custom synthesis, contract manufacturing and product sourcing.
As a global maker of Azithromycin, Alpha lipoic acid, etc, SIPI Pharma prides itself in exporting since 1996. It's export turnover hit 10 millions USD in 2005.
SIPI Pharma is strong&competitive in exporting outsourcing products of chinese origin. Actually the strength comes from SIPI's extensive relationship with large number of chinese pharma manufacturers, who are transferees&beneficiaries of the research findings of SIPI.